. Author manuscript; available in PMC: 2016 Nov 1.

Published in final edited form as: Am J Med. 2015 Jul 11;128(11):1252.e1–1252.e11. doi: 10.1016/j.amjmed.2015.06.030

Table 2.

Clinical Outcomes Over One Year: Analysis of secondary prevention following myocardial infarction for statin initiators compared to statin non-initiators. Hazard ratios and 95% confidence intervals were estimated from Cox proportional hazards regression

	Statin Initators (n=5,597)		Statin Non-initiators (n=5,583)		PS Matched and Adjusted Hazard Ratio (95% CI)

	Events	Events per 100 person years	Events	Events per 100 person years
Death	614	11.93	904	18.47	0.79 (0.71, 0.88)
P-value for interaction of statin initiation by level of kidney function					0.86
CV Hospitalization	805	16.84	850	18.74	0.90 (0.82, 1.00)
P-value for interaction of statin initiation by level of kidney function					0.77